EANM guideline on quality risk management for radiopharmaceuticals
Nic Gillings, Olaug Hjelstuen, Martin Béhé, Clemens Decristoforo, Philip H. Elsinga, Valentina Ferrari, Oliver Kiss, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Meltem Ocak, Marianne Patt, Sergio Todde, Almut Walte
Abstract
This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
Topics & Concepts
GuidelineMedicineMedical physicsQuality managementQuality (philosophy)PathologyEngineeringOperations managementManagement systemEpistemologyPhilosophyRadiopharmaceutical Chemistry and ApplicationsGraphite, nuclear technology, radiation studiesNuclear and radioactivity studies